These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Hemolytic-uremic syndrome in a young woman following the use of ovulation inhibitors]. Blumberg A; Studer U; Briner J Schweiz Med Wochenschr; 1975 Oct; 105(41):1324-7. PubMed ID: 1215910 [TBL] [Abstract][Full Text] [Related]
3. Late recovery of renal function in a woman with the hemolytic uremic syndrome. Ponticelli C; Maestri O; Imbasciati E; Brancaccio D; Rossi E Clin Nephrol; 1977 Aug; 8(2):367-70. PubMed ID: 891050 [TBL] [Abstract][Full Text] [Related]
4. Action of hormonal contraceptives on the coagulation system and some of its inhibitors. Misz M; Beck P Acta Med Hung; 1986; 43(3):301-10. PubMed ID: 2438639 [TBL] [Abstract][Full Text] [Related]
5. The relationship between vascular headaches and low-dose oral contraceptives. Karsay K Ther Hung; 1990; 38(4):181-5. PubMed ID: 2094059 [TBL] [Abstract][Full Text] [Related]
6. Examination of the potential interaction between ketoconazole (Nizoral) and oral contraceptives with special regard to products of low hormone content (Rigevidon, anteovin). Kovács I; Somos P; Hámori M Ther Hung; 1986; 34(3):167-70. PubMed ID: 3441880 [No Abstract] [Full Text] [Related]
7. [Hemolytic-uremic syndrome caused by estrogen-progestagen combined oral contraceptives]. Otero González A; Santos C; Jiménez JL; Gil J; Sánchez-Guisande D; Temes Montes XL Med Clin (Barc); 1984 May; 82(18):824. PubMed ID: 6429463 [No Abstract] [Full Text] [Related]
8. Observations with a combined oral contraceptive (Rigevidon) containing minimum oestrogen dose. Karsay K Ther Hung; 1980; 28(1):17-20. PubMed ID: 7281074 [TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of Rigevidon used for contraception]. Marianowski L; Grezechocińska B Ginekol Pol; 1984 Aug; 55(8):631-5. PubMed ID: 6396173 [TBL] [Abstract][Full Text] [Related]
10. [Acceptability of hormonal contraceptives with a low steroid content]. Dubnitskaia LV Akush Ginekol (Mosk); 1988 Aug; (8):47-50. PubMed ID: 3195708 [TBL] [Abstract][Full Text] [Related]
11. Experience with hormonal contraceptives. Kulakov VI Acta Med Hung; 1986; 43(2):93-6. PubMed ID: 3588163 [TBL] [Abstract][Full Text] [Related]
12. Observations with Anteovin in relation to age. Szigethy A Ther Hung; 1991; 39(1):11-5. PubMed ID: 1858069 [TBL] [Abstract][Full Text] [Related]
14. Rigevidon (clinical trial of the preparation). Kliment V; Ziak F Ther Hung; 1981; 29(2):94-5. PubMed ID: 6765144 [TBL] [Abstract][Full Text] [Related]
15. Mesenteric venous thrombosis associated with pregnancy and oral contraception. A case report. Graubard ZG; Friedman M S Afr Med J; 1987 Apr; 71(7):453. PubMed ID: 3563797 [TBL] [Abstract][Full Text] [Related]
16. [Paget-Schroetter syndrome caused by the use of oral contraceptives]. Steiner A; Millei J; Ján H; Erös L Orv Hetil; 1982 Sep; 123(39):2419-21. PubMed ID: 7145407 [No Abstract] [Full Text] [Related]
17. [Systemic changes during the use of hormonal contraceptives]. Manuilova IA; Trutko NS; Dubnitskaia LV; Kuramshina AKh Akush Ginekol (Mosk); 1983 Nov; (11):14-7. PubMed ID: 6666789 [TBL] [Abstract][Full Text] [Related]
18. Retinal manifestations of thrombotic thrombocytopenic purpura (TTP) following use of contraceptive treatment. Snir M; Cohen S; Ben-Sira I; Buckman G Ann Ophthalmol; 1985 Feb; 17(2):109-12. PubMed ID: 4039547 [TBL] [Abstract][Full Text] [Related]
19. [Systemic lupus erythematosus during therapy with oral estrogen-progestin. Considerations apropos of a case]. Gueli N; Toto A; Tartaglione E; Lucianetti MC; Screnci M; Sauli V; Carmenini G Clin Ter; 1987 May; 121(4):299-304. PubMed ID: 2973866 [No Abstract] [Full Text] [Related]
20. [Esophageal ulcer caused by the "pill"]. Allmendinger G Z Gastroenterol; 1985 Oct; 23(10):531-3. PubMed ID: 4082685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]